Previous 10 | Next 10 |
Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am happy to be joined by Ronan Levy, Chief Strategy Officer at Trait Biosciences, a cannabis biotech firm....
Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am excited to be joined by Joe Lusardi, President & CEO of Curaleaf (CURLF), a vertically integrated m...
The FDA has reopened its 30-day comment period related to international drug scheduling on cannabis products. A delay from the World Health Organization disrupted the original schedule. More news on: Cronos Group Inc., Tilray, Inc., Aurora Cannabis Inc., Healthcare stocks news, Consumer ...
Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am happy to be joined by David Sandelman, Chief Engineer at Cannatrol, a precision drying/curing system fo...
Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am very happy to be joined by David Brough, CEO of Klonetics Plant Science. He's also President at Precisi...
The broad market's sell-off notwithstanding, cannabis stocks are under pressure after Tilray reported Q2 results after the close yesterday. Revenues were up 371% to $45.9M, albeit from a low base. Investors appear to be reacting to its disclosure that the average price per gram sold droppe...
Listen on the go! Subscribe to The Cannabis Investing Podcast on Apple Podcasts , Google Podcasts , Spotify , and Stitcher . By Rena Sherbill Today, I am very happy to be joined by Dr. Kyle Kingsley, the founder and CEO of Vireo Health (VREOF), a publicly t...
By Tyler Andries For the month of July, the ETF Deathwatch increased in size. Twenty-four exchange-traded products ("ETPs") were added to the list, and 19 funds were removed, making July a busier month in terms of additions. Of the removals, 16 were removed due to increased health, and three...
Listen on the go! Subscribe to The Cannabis Investing Podcast on Libsyn , Spotify , Stitcher or Apple Podcasts . By Jonathan Liss Today I am very happy to welcome Dan Ahrens, manager of the recently launched AdvisorShares Pure Cannabis ETF ( YOLO ) to the ...
Listen on the go! Subscribe to The Cannabis Investing Podcast on Libsyn , Spotify , Stitcher or Apple Podcasts . By Rena Sherbill Today, I am very happy to be joined by Vitaliy Katsenelson, CFA. Vitaliy is Chief Investment Officer at Investment Management...
News, Short Squeeze, Breakout and More Instantly...
AdvisorShares Vice ETF Company Name:
ACT Stock Symbol:
NASDAQ Market:
AdvisorShares Vice ETF Website:
GAAP Net Income of $184 million , or $1.16 per diluted share Adjusted Operating Income of $201 million , or $1.27 per diluted share Return on Equity of 15.4% and Adjusted Operating Return on Equity...
Dayforce Inc. (DAY) is expected to report $0.18 for Q2 2024 D/B/A Compass Diversified Holdings Shares of Beneficial Interest (CODI) is expected to report $0.44 for Q2 2024 Aurora Innovation Inc. (AUR) is expected to report for Q2 2024 Autohome Inc. American Depositary Shares each repr...
RALEIGH, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) announced it will issue its second quarter earnings release after the market closes on July 31, 2024. Enact will host a conference call to review second quarter 2024 financial results on August 1, 2024...